Acute inhibition of Ca2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 2, 2009, Pages 650-659

  Chen, Yan ^a   Luo, Fang ^a   Yang, Cheng ^a   Kirkmire, Chelsea M ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [N (4 METHOXYBENZENESULFONYL)]AMINO N (4 CHLOROCINNAMYL) N METHYLBENZYLAMINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; KN 92; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE INHIBITOR; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; BENZYLAMINE DERIVATIVE; SULFONAMIDE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME INHIBITION; HYPERALGESIA; LOCOMOTION; MALE; MOUSE; NEUROMODULATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; METHODOLOGY; NEURALGIA; PAIN ASSESSMENT; PHYSIOLOGY; TIME;

ANIMALS; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED ICR; NEURALGIA; PAIN MEASUREMENT; PROTEIN KINASE INHIBITORS; SULFONAMIDES; TIME FACTORS;

EID: 67651064669     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.152165     Document Type: Article

References (43)

1. Brüggemann I, Schulz S, Wiborny D, and Höllt V (2000) Colocalization of the mu-opioid receptor and calcium/calmodulin-dependent kinase II in distinct painprocessing brain regions. Brain Res Mol Brain Res 85:239-250.
2. Carlton SM (2002) Localization of CaMKIIalpha in rat primary sensory neurons: increase in inflammation. Brain Res 947:252-259. (Pubitemid 34899512)
3. Chaplan SR, Bach FW, Pogrel JW, Chung JM, and Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55-63.
4. 2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model. Brain Res 1108:28-38.
5. 2+/calmodulin-dependent protein kinase II in the spinal cord contributes to neuropathic pain in a rat model of mononeuropathy. Eur J Neurosci 21:2467-2474.
6. DeLong RE, Barraco RA, and Phillis JW (1985) Behavioral interaction of adenosine and trifluoperazine in mice. Neurosci Lett 53:101-107.
7. Dickenson AH, Chapman V, and Green GM (1997) The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol 28:633-638. (Pubitemid 27244410)
8. Dina OA, Barletta J, Chen X, Mutero A, Martin A, Messing RO, and Levine JD (2000) Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 20:8614-8619.
9. Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441-462.
10. Dubner R and Ruda MA (1992) Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 15:96-103.
11. 2+ response to electrical stimulation in normal and injured sensory neurons, with increased inhibition of calcitonin gene-related peptide expressing neurons after injury. Neuroscience 131:189-197.
12. Garry EM, Moss A, Delaney A, O'Neill F, Blakemore J, Bowen J, Husi H, Mitchell R, Grant SG, and Fleetwood-Walker SM (2003) Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr Biol 13:321-328. (Pubitemid 36230023)
13. Golbidi S, Moriuchi H, Irie T, Ghafghazi T, and Hajhashemi V (2002) Involvement of calmodulin inhibition in analgesia induced with low doses of intrathecal trifluoperazine. Jpn J Pharmacol 88:151-157. (Pubitemid 34223564)
14. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88. (Pubitemid 18149685)
15. Hua XY, Chen P, and Yaksh TL (1999) Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett 276:99-102. (Pubitemid 29525499)
16. Hylden JL and Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67:313-316. (Pubitemid 10007057)
17. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
18. 2+ channels. Science 302:117-119.
19. Kim SH and Chung JM (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
20. Kitamura Y, Miyazaki A, Yamanaka Y, and Nomura Y (1993) Stimulatory effects of protein kinase C and calmodulin kinase II on N-methyl-D-aspartate receptor/channels in the postsynaptic density of rat brain. J Neurochem 61:100-109. (Pubitemid 23175888)
21. Lisman J, Schulman H, and Cline H (2002) The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3:175-190. (Pubitemid 135706588)
22. 2+/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 325:267-275.
23. Malmberg AB, Chen C, Tonegawa S, and Basbaum AI (1997) Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 278:279-283. (Pubitemid 27450873)
24. Marques LO, Lima MS, and Soares BG (2004) Trifluoperazine for schizophrenia. Cochrane Database Syst Rev, CD003545.
25. McMahon SB, Lewin GR, and Wall PD (1993) Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 3:602-610.
26. Ogawa A, Dai Y, Yamanaka H, Iwata K, Niwa H, and Noguchi K (2005) Ca(2+)/calmodulin-protein kinase IIalpha in the trigeminal subnucleus caudalis contributes to neuropathic pain following inferior alveolar nerve transection. Exp Neurol 192:310-319. (Pubitemid 40341677)
27. Pezet S, Marchand F, D'Mello R, Grist J, Clark AK, Malcangio M, Dickenson AH, Williams RJ, and McMahon SB (2008) Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci 28:4261-4270.
28. Price TJ, Jeske NA, Flores CM, and Hargreaves KM (2005) Pharmacological interactions between calcium/calmodulin-dependent kinase II alpha and TRPV1 receptors in rat trigeminal sensory neurons. Neurosci Lett 389:94-98.
29. Reiss AJ Jr, Miczek KA, and Roth JA (1994) Understanding and Preventing Violence, Volume 2: Biobehavioral Influences. Panel on the Understanding and Control of Violent Behaviors, National Research Council. National Academy Press, Washington, DC.
30. Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, and Tanabe T (2001) Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. EMBO J 20:2349-2356. (Pubitemid 32452852)
31. Seltzer Z, Cohn S, Ginzburg R, and Beilin B (1991) Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 45:69-75.
32. Strack S, Choi S, Lovinger DM, and Colbran RJ (1997) Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J Biol Chem 272:13467-13470. (Pubitemid 27224771)
33. Tang L, Chen Y, Chen Z, Blumberg PM, Kozikowski AP, and Wang ZJ (2007) Antinociceptive pharmacology of N-(4-chlorobenzyl)-N′-(4-hydroxy-3-iodo-5- methoxybenzyl) thiourea (IBTU), a high-affinity competitive antagonist of the transient receptor potential vanilloid 1 receptor. J Pharmacol Exp Ther 321:791-798.. (Pubitemid 46624524)
34. Tang L, Shukla PK, Wang LX, and Wang ZJ (2006a) Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 317:901-909.
35. Tang L, Shukla PK, and Wang ZJ (2006b) Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive tolerance. Neurosci Lett 397: 1-4. (Pubitemid 43340448)
36. Wang S, Lim G, Zeng Q, Sung B, Yang L, and Mao J (2005) Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 25:488-495. (Pubitemid 40105620)
37. Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP Jr, Lai J, and Porreca F (2001) Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21:1779-1786. (Pubitemid 32182217)
38. Willis WD (2001) Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 933:142-156.
39. Womack MD, MacDermott AB, and Jessell TM. (1988) Sensory transmitters regulate intracellular calcium in dorsal horn neurons. Nature 334:351-353.
40. Woolf CJ (2007) Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology 106:864-867.
41. Woolf CJ and Thompson SW (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44:293-299.
42. Zeitz KP, Giese KP, Silva AJ, and Basbaum AI (2004) The contribution of autophosphorylated alpha-calcium-calmodulin kinase II to injury-induced persistent pain. Neuroscience 128:889-898.
43. Zhang RX, Ruda MA, and Qiao JT (1998) Pre-emptive intrathecal Mk-801, a noncompetitive N-methyl-D-aspartate receptor antagonist, inhibits the up-regulation of spinal dynorphin mRNA and hyperalgesia in a rat model of chronic inflammation. Neurosci Lett 241:57-60.